In a retrospective cohort of 54 thyroid cancers, the large majority of malignant lesions (92.5%) displayed a strong expression of BHLHE40 specifically in tumor cells, while normal adjacent thyroid tissue did not express BHLHE40 [77]. Here, BHLHE40 is linked to thyroid cancer.